Kerafast
Boston, US · Founded 2010 · Delaware corporation · 1 known investors
Find your way into Kerafast
Each arrow is one introduction. Sign up to fill in the first one.
Ask Phil Schwarz to introduce you to Jennifer Rossi
You →Phil · together at Ohio University →Jennifer
Sign up to find every way you can get introduced to Kerafast
- Your email: who you already know at Kerafast, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kerafast team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Kerafast is an online marketplace that distributes laboratory reagents and research materials sourced from academic and research institutions, making individual scientists' unique reagents available to the global research community. It serves life science researchers and connects laboratories that produce specialized reagents with those seeking them.
Founders & leadership

Board




Investors · 1
How we know: FCA Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 3 rounds · 2012–2016
▶$250KraisedMar 2016 · 1 investors · OtherRule 506(c)
- Kim WestmorelandDirector
- Robert P BondarykExecutive Officer, Director
- Andrew BouldinDirector
- William EmhiserDirector
- Matthew KingDirector
- Offering amount
- $1.1M
- Amount sold
- $250K
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$634.8KraisedApr 2015 · 11 investors · OtherRule 506(b)
- Andrew BouldinDirector
- Kim D WestmorelandDirector
- William EmhiserDirector
- Jennifer RossiExecutive Officer
- Matthew A KingDirector
- Robert P BondarykExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $634.8K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$500KraisedMar 2012 · 1 investors · BiotechnologyRule 506(b)
- Matthew L. KingDirector
- William C. EmhiserExecutive Officer, Director
- John E. BurchDirector
- Kim D. WestmorelandDirector
- Robert P. BondarykExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $500K
- Proceeds to insiders
- $12.5K
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Kerafast.
Frequently asked questions
- What does Kerafast do?
- Kerafast is an online marketplace that distributes laboratory reagents and research materials sourced from academic and research institutions, making individual scientists' unique reagents available to the global research community. It serves life science researchers and connects laboratories that produce specialized reagents with those seeking them.
- Who are Kerafast's investors?
- Kerafast's investors include FCA Venture Partners.
- How much funding has Kerafast raised?
- Kerafast has disclosed $1.4M raised across 3 rounds.
- Where is Kerafast headquartered?
- Kerafast is headquartered in Boston, US.

